课题基金 / 基金详情

Driving protective immune responses by targeting Mycobacterium bovis and Foot-and-Mouth Disease virus antigens to bovine dendritic cell subsets

Driving protective immune responses by targeting Mycobacterium bovis and Foot-and-Mouth Disease virus antigens to bovine dendritic cell subsets
通过将牛分枝杆菌和口蹄疫病毒抗原靶向牛树突状细胞亚群来驱动保护性免疫反应
批准号:
BB/F013590/1
负责人:
Bryan Charleston
金额:
$101.95万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2009
资助国家:
英国
项目状态:
已结题
起止时间:
2009 至 --

项目摘要

项目成果

Bryan Charleston的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
These studies will help design new vaccines for two important diseases of cattle, bovine tuberculosis and Foot-and-Mouth disease virus. Mycobacterium bovis is the causative agent of bovine tuberculosis (TB), a disease increasing in incidence in UK cattle herds causing major economic losses and potential human health risks. At present control of bovine TB relies solely on the use of diagnostic tests which do not have 100% sensitivity or specificity. Foot and mouth disease virus (FMDV) has a wide host range including all cloven-hoofed animals and causes an acute vesicular disease in domestic ruminants and pigs, which results in debilitation, pain and loss of productivity. Vaccines have been shown to be highly valuable in controlling a variety of infectious diseases, including bacteria and viruses. However, effective vaccines require portions of the infectious agent to be delivered to specialised cells, called dendritic cells. Dendritic cells are the only cells in the body capable of starting an immune response to an agent the body hasn't seen before. Targeting portions of the infectious agents to dendritic cells has been shown to stimulate a strong immune response. Unfortunately, the situation is more complicated than it first appears, there is more than one type of dendritic cell and each cell type can stimulate a different type of immune response. Specific immune responses may be required to control different infections. Acute viral infections, for example Foot-and-Mouth disease, may require an antibody response to control infection. In contrast, slow growing bacterial infections, for example tuberculosis may require immune T cells to control them. In this programme of work we plan to target components of Foot-and-Mouth disease virus or cattle tuberculosis bacteria to particular dendritic cell subsets to determine whther a protective immune response can be stimulated
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1099/jgv.0.000581
发表时间: 2016-10
期刊: The Journal of general virology
影响因子: --
作者: [Guzman E, Taylor G, Hope J, Herbert R, Cubillos-Zapata C, Charleston B]
通讯作者: Charleston B
DOI: 10.1016/j.vaccine.2015.01.042
发表时间: 2015-02-25
期刊: Vaccine
影响因子: 5.5
作者: [Dicks MD, Guzman E, Spencer AJ, Gilbert SC, Charleston B, Hill AV, Cottingham MG]
通讯作者: Cottingham MG
BBSRC Pathfinder IAA Pirbright Institute
  • 批准号:
    BB/X511134/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $50.33万
  • 财政年份:
    2022
  • 负责人:
    Bryan Charleston
  • 依托单位:
[Monkey Pox] Rapid Research Response
  • 批准号:
    BB/X011542/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $84.41万
  • 财政年份:
    2022
  • 负责人:
    Bryan Charleston
  • 依托单位:
BBSRC IAA The Pirbright Institute
  • 批准号:
    BB/S506680/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $55.43万
  • 财政年份:
    2018
  • 负责人:
    Bryan Charleston
  • 依托单位:
UK Veterinary Vaccinology Network
  • 批准号:
    BB/M005224/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $39.16万
  • 财政年份:
    2015
  • 负责人:
    Bryan Charleston
  • 依托单位:
国内基金
海外基金
内源性蛋白酶抑制剂SerpinA3N对缺血性脑卒中后血脑屏障的保护作用及其表达调控机制
  • 批准号:
    82371317
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    万杰清
  • 依托单位: